3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Endocrine
1
Conditions
Carcinoma, Non-Small-Cell Lung
266
Lung Neoplasms
102
Adenocarcinoma of Lung
28
Mesothelioma, Malignant
24
Mesothelioma
22
Neoplasms
18
Meningeal Carcinomatosis
18
Brain Neoplasms
16
Head and Neck Neoplasms
14
Neoplasm Metastasis
13
Ovarian Neoplasms
9
NSCLC
9
Colorectal Neoplasms
8
Adenocarcinoma, Bronchiolo-Alveolar
8
Breast Neoplasms
7
Recurrence
6
Carcinoma, Transitional Cell
6
Squamous Cell Carcinoma of Head and Neck
5
Prostatic Neoplasms
5
Pancreatic Neoplasms
5
Lymphoma
5
Esophageal Neoplasms
5
Unspecified Adult Solid Tumor, Protocol Specific
4
Sarcoma
4
Non-squamous Non-small Cell Lung Cancer
4
Non-small Cell Lung Cancer Metastatic
4
Fallopian Tube Neoplasms
4
Adenocarcinoma
4
Urinary Bladder Neoplasms
3
Stomach Neoplasms
3
Interventions
Iodine-131
14
trametinib
9
dabrafenib
9
Thyroidectomy
9
Surgical Procedures, Operative
9
lenvatinib
8
Thyroxine
8
Magnetic Resonance Spectroscopy
8
pembrolizumab
7
Paclitaxel
7
anlotinib
6
Thyrotropin Alfa
6
selpercatinib
5
Sorafenib
5
Saline Solution
5
Radiofrequency Ablation
5
Everolimus
5
pazopanib
4
Vemurafenib
4
Sunitinib
4
Radiotherapy
4
Nivolumab
4
Fluorodeoxyglucose F18
4
Dexmedetomidine
4
Cyclophosphamide
4
Biopsy, Fine-Needle
4
Biopsy
4
Bevacizumab
4
apatinib
3
Triiodothyronine
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Thyroid Neoplasms
×
Pemetrexed
×
Clear all
NCT00786552
2011-01-20
Panthera
University Hospital Schleswig-Holstein
Phase 2
Unknown
47 enrolled